Results 121 to 130 of about 3,798,723 (244)

Neuraminidase in Virus-like Particles Contributes to the Protection against High Dose of Avian Influenza Virus Challenge Infection [PDF]

, 2021
Hae-Ji Kang, Ki-Back Chu, Keon-Woong Yoon, Gi-Deok Eom, Jie Mao, Min-Ju Kim, Su-Hwa Lee, Eun‐Kyung Moon, Fu‐Shi Quan   +8 more
openalex   +1 more source

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Clinical pharmacology and therapy, 2017
J. Hicks, K. Sangkuhl, J. Swen, V. Ellingrod, Daniel J. Müller, K. Shimoda, J. Bishop, E. Kharasch, T. Skaar, A. Gaedigk, H. M. Dunnenberger, T. Klein, K. Caudle, J. Stingl   +13 more
semanticscholar   +1 more source

Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 Diabetes. [PDF]

, 2017
The clinical benefits of real time continuous glucose monitoring (rtCGM) use have been well demonstrated in both CSII- and MDI-treated individuals in large clinical trials. However, recommendations for patient use of rtCGM in everyday life situations are
Edelman, Steven V, Pettus, Jeremy
core  

Ret/PTC Activation in Benign and Malignant Thyroid Tumors Arising in a Population Exposed to Low-Dose External-Beam Irradiation in Childhood [PDF]

, 2004
Siegal Sadetzki, Ronit Calderon‐Margalit, Baruch Modan, Shefali Srivastava, R. Michael Tuttle   +4 more
openalex   +1 more source

Unintentional ingestion of a high dose of acenocoumarol in a young child [PDF]

, 2021
Martijn R Brands, Jelmer Sytema, Marinus van Hulst, Arvid W.A. Kamps   +3 more
openalex   +1 more source

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update

Clinical pharmacology and therapy, 2017
Julie A. Johnson, K. Caudle, L. Gong, Michelle Whirl‐Carrillo, C. Stein, S. Scott, M. M. Lee, B. Gage, S. Kimmel, M. Perera, Jeffrey L. Anderson, M. Pirmohamed, T. Klein, N. Limdi, L. Cavallari, M. Wadelius   +15 more
semanticscholar   +1 more source

Population pharmacokinetic modeling to facilitate dose selection of tapentadol in the pediatric population

Journal of Pain Research, 2019
Estelle Watson,1 Akash Khandelwal,1 Jan Freijer,1 John van den Anker,2,3 Claudia Lefeber,1 Mariëlle Eerdekens1 1Grünenthal GmbH, Aachen, Germany; 2Division of Paediatric Pharmacology and Pharmacometrics, University of Basel Children’s ...
Watson E, Khandelwal A, Freijer J, van den Anker J, Lefeber C, Eerdekens M   +5 more
doaj  

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors

Clinical pharmacology and therapy, 2015
J. Hicks, J. Bishop, K. Sangkuhl, Daniel J. Müller, Y. Ji, SG Leckband, J. Leeder, Rebecca L. Graham, DL Chiulli, A. Llerena, T. Skaar, S. Scott, J. Stingl, T. Klein, K. Caudle, A. Gaedigk   +15 more
semanticscholar   +1 more source

The effect of dose level of essential fatty acids upon fatty acid composition of the rat liver

, 1963
Hans Mohrhauer, Ralph T. Holman
openalex   +1 more source

Local Delivery of CTLA-4 Blockade Inhibits Growth of Pancreatic Tumors [PDF]

, 2016
Immune checkpoint blockade has demonstrated great potential in activating antitumor immunity. Ipilimumab is a monoclonal antibody which targets cytotoxic T-lymphocyte antigen-4. CTLA-4 belongs to the CD28 class of receptors and is found on the surface of
Baltz, Jack
core   +2 more sources